No Cover Image

Journal article 346 views

The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions / Wu Li-Tzy; Andy C Parrott; Christopher L Ringwalt; Chongming Yang; Dan G Blazer

American Journal on Addictions, Volume: 18, Issue: 6, Pages: 452 - 461

Swansea University Author: Parrott, Andrew

Full text not available from this repository: check for access using links below.

Abstract

This study investigated the heterogeneity of ecstasy or MDMA (3,4-methylenedioxy-N-methylamphetamine) users. Data came from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Latent class analysis (LCA) and multinomial logistic regression procedures were used to...

Full description

Published in: American Journal on Addictions
ISSN: 1055-0496 1521-0391
Published: 2009
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa9307
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: This study investigated the heterogeneity of ecstasy or MDMA (3,4-methylenedioxy-N-methylamphetamine) users. Data came from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Latent class analysis (LCA) and multinomial logistic regression procedures were used to identify subtypes of ecstasy users. Approximately 1.6% (n=562) of adult participants (N=43,093) reported lifetime ecstasy/MDMA use. LCA identified three subtypes of ecstasy/MDMA users. Class 1 exhibited pervasive use of most drug classes (ecstasy–polydrug users, 37%). Class 2 reported a high rate of use of marijuana and cocaine and a moderate use of amphetamines (ecstasy–marijuana–stimulant users, 29%). Class 3 was characterized by a high rate of use of marijuana and a low use of primarily prescription-type drugs (ecstasy– marijuana users, 34%). Subtypes were distinguished by family income, history of substance abuse treatment, and familial substance abuse. Class 1 exhibited the highest prevalence of disorders related to the use of marijuana (77%), tobacco (66%), amphetamines (36%), opioids (35%), sedatives (31%), and tranquilizers (30%). The recent resurgence in ecstasy use among adults underscores the need to monitor trends in its use.
College: College of Human and Health Sciences
Issue: 6
Start Page: 452
End Page: 461